Ftse Mib
33.834,91
0,00%
DAX
18.325,58
0,77%
S&P 500
5.447,87
-0,31%
NASDAQ
17.496,82
-1,09%
Bitcoin
61.057,84
1,32%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Janux Therapeutics Inc (JANX) Janux Therapeutics Inc (JANX) Notizie

Janux Therapeutics Inc

JANX
43,22
2,26 (5,52%)
25 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/6/202423:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
04/6/202401:02EDGAR2Form 144 - Report of proposed sale of securities
08/5/202415:13EDGAR2Form S-3ASR - Automatic shelf registration statement of..
07/5/202422:01BWJanux Therapeutics Reports First Quarter 2024 Financial..
08/3/202422:47EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/3/202422:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/3/202422:11EDGAR2Form 8-K - Current report
08/3/202422:01BWJanux Therapeutics Reports Fourth Quarter and Full Year 2023..
29/2/202423:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202423:11EDGAR2Form 8-K - Current report
29/2/202407:22BWJanux Therapeutics Announces Pricing of $296.5 Million..
29/2/202403:55EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
28/2/202423:15EDGAR2Form 8-K - Current report
28/2/202403:50EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/2/202423:23EDGAR2Form 8-K - Current report
27/2/202423:00BWJanux Therapeutics Announces Proposed Public Offering of..
26/2/202422:05BWJanux Announces Encouraging Safety and Efficacy Data in..
20/2/202414:00BWJanux Therapeutics to Host Virtual Event Discussing Updated..
09/2/202422:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202415:00BWJanux Therapeutics Promotes Co-Founder Tommy DiRaimondo,..
03/1/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/11/202322:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:07EDGAR2Form 8-K - Current report
07/11/202322:01BWJanux Therapeutics Reports Third Quarter 2023 Financial..
08/9/202300:14EDGAR2Form 144 - Report of proposed sale of securities
14/8/202322:33EDGAR2Form 144 - Report of proposed sale of securities
08/8/202322:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:17EDGAR2Form 8-K - Current report
08/8/202322:01BWJanux Therapeutics Reports Second Quarter 2023 Financial..
18/7/202323:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/7/202322:16EDGAR2Form 8-K - Current report
17/7/202314:45BWJanux Therapeutics Announces Pricing of $60 Million..
17/7/202314:16EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
17/7/202314:06EDGAR2Form 8-K - Current report
17/7/202314:00BWJanux Therapeutics Announces Positive Interim Clinical Data..
Apertura: 41,06 Min: 40,18 Max: 44,05
Chiusura: 40,96

La tua Cronologia

NASDAQ
JANX
Janux Therapeutics
NYSE
NQ
BIT
P20NZ1
NLBNPIT20NZ1 20240918 5800
DGFX
CANDYUSDT
CANDY
COIN
DGOREBTC
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network